Approvals/TGA/MOXIFLOXACIN KABI moxifloxacin (as hydrochloride) 400mg/250mL intravenous infusion injection bag

Approved

STANDARD

MOXIFLOXACIN KABI moxifloxacin (as hydrochloride) 400mg/250mL intravenous infusion injection bag

Fresenius Kabi Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: d4837efb115d5b9a
Product Name: MOXIFLOXACIN KABI moxifloxacin (as hydrochloride) 400mg/250mL intravenous infusion injection bag
Artg Id: 241252
Artg Name: MOXIFLOXACIN KABI moxifloxacin (as hydrochloride) 400mg/250mL intravenous infusion injection bag
Sponsor: Fresenius Kabi Australia Pty Ltd
Company Detail Path: /organization/fresenius-kabi-australia-pty-ltd
Artg Date: 2016-05-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/7160fa7ae0a7d17261e23199a4318fc2.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/881f4fb8e3452b29376311c17d24a5fb.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

d4837efb115d5b9a

Type

Standard